Insulet initiated with an Equal Weight at Barclays
Upside potential under a neutral stance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential under a neutral stance.
What happened, with direct paths to the underlying reporting
Barclays initiates Insulet with an Equal Weight rating; target price $150 vs. current price $134.73.
Target: $150
Posted price: $134.73
Analyst firm: Barclays
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.